Provided by Tiger Fintech (Singapore) Pte. Ltd.

Compugen

1.44
-0.0400-2.70%
Post-market: 1.440.00000.00%18:37 EDT
Volume:75.28K
Turnover:108.60K
Market Cap:134.66M
PE:-9.00
High:1.47
Open:1.44
Low:1.42
Close:1.48
Loading ...

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts

Insider Monkey
·
23 Mar

Truist Financial Reaffirms Their Buy Rating on Compugen (CGEN)

TIPRANKS
·
05 Mar

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

GuruFocus.com
·
05 Mar

Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability

TIPRANKS
·
05 Mar

Compugen Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
05 Mar

Press Release: /C O R R E C T I O N -- Compugen Ltd./

Dow Jones
·
04 Mar

Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
04 Mar

Compugen: Q4 Earnings Snapshot

Associated Press Finance
·
04 Mar

Compugen Had Approximately $103.3M In Cash, Cash Equivalents, Short-term Bank Deposits And Investment In Marketable Securities, Subsequent To The Financial Results The Company Raised Net Proceeds Of Approximately $8.87M Via ATM Facility, With Cash Runway Expected To Fund Operations Into 2027

Benzinga
·
04 Mar

Compugen Q4 2024 GAAP EPS $(0.07) May Not Be Comparable To $0.07 Estimate, Sales $1.47M May Not Be Comparable To $17.43M Estimate

Benzinga
·
04 Mar

Compugen Reports Fourth Quarter and Full Year 2024 Results

PR Newswire
·
04 Mar

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference

PR Newswire
·
03 Mar

Compugen Ltd expected to post earnings of 7 cents a share - Earnings Preview

Reuters
·
28 Feb

Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology

PR Newswire
·
26 Feb

Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025

PR Newswire
·
18 Feb

Compugen Announces Significant Share Price Increase

TIPRANKS
·
18 Feb

Compugen Updates Filing Structure with Bristol Myers Squibb

TIPRANKS
·
16 Feb

Has Compugen Ltd.'s (NASDAQ:CGEN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.
·
14 Jan

Compugen Ltd : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $4

THOMSON REUTERS
·
13 Jan

Oppenheimer Reaffirms Their Buy Rating on Compugen (CGEN)

TIPRANKS
·
13 Jan